Bolt Biotherapeutics (BOLT) Earnings Date, Estimates & Call Transcripts $0.35 +0.00 (+0.71%) Closing price 05/2/2025 03:48 PM EasternExtended Trading$0.35 -0.01 (-2.12%) As of 05/2/2025 06:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipShort InterestTrendsBuy This Stock Bolt Biotherapeutics Earnings Summary Upcoming Earnings DateMay. 13Before Market OpensEstimatedConsensus EPS (Mar. 24) -$0.38 Actual EPS (Mar. 24) -$0.38 Actual Revenue (Mar. 24) $0.01MBolt Biotherapeutics announced Q4 2024 earnings on March 24, 2025, reporting an EPS of -$0.38, which met analysts' consensus estimates of -$0.38. Quarterly revenue was reported to be $0.01 million, below the consensus estimate of $0.79 million. With a trailing EPS of -$1.66, Bolt Biotherapeutics' earnings are expected to grow next year, from ($1.61) to ($1.12) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings Report Annual Report (10-K) Press Release (8-K)BOLT Upcoming EarningsBolt Biotherapeutics' Q1 2025 earnings is scheduled for Tuesday, May 13, 2025, with a conference call scheduled at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q1 2025 Earnings ReportPowered by Get Bolt Biotherapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Bolt Biotherapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataBOLT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.BOLT Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Bolt Biotherapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.34-$0.33-$0.34Q2 20252-$0.34-$0.32-$0.33Q3 20252-$0.35-$0.33-$0.34Q4 20252-$0.35-$0.34-$0.35 FY 2025 8 -$1.38 -$1.32 -$1.35 Q1 20261-$0.36-$0.36-$0.36Q2 20261-$0.16-$0.16-$0.16Q3 20261-$0.16-$0.16-$0.16Q4 20261-$0.16-$0.16-$0.16 Bolt Biotherapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/13/2025(Estimated)-------3/24/2025Q4 2024-$0.38-$0.38--$0.42$0.79M$0.01M11/12/2024--$0.36-$0.40 -$0.04-$0.40$1.02M$1.14M8/13/2024Q2 2024-$0.48-$0.56 -$0.08-$0.56$1.19M$1.28M5/14/2024Q1 2024-$0.51-$0.28+$0.23-$0.28$2.63M$5.27M3/21/2024Q4 2023-$0.47-$0.47--$0.47$1.97M$2.09M11/9/2023Q3 2023-$0.49-$0.43+$0.06-$0.43$1.60M$2.53M8/7/2023Q2 2023-$0.53-$0.48+$0.05-$0.48$1.69M$1.43M5/11/2023Q1 2023-$0.49-$0.45+$0.04-$0.45$1.67M$1.83M Bolt Biotherapeutics Earnings - Frequently Asked Questions When is Bolt Biotherapeutics's earnings date? Bolt Biotherapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 13th, 2025 based off last year's report dates. Learn more on BOLT's earnings history. Did Bolt Biotherapeutics beat their earnings estimates last quarter? In the previous quarter, Bolt Biotherapeutics (NASDAQ:BOLT) reported ($0.38) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.38). Learn more on analysts' earnings estimate vs. BOLT's actual earnings. How much revenue does Bolt Biotherapeutics generate each year? Bolt Biotherapeutics (NASDAQ:BOLT) has a recorded annual revenue of $7.69 million. How much profit does Bolt Biotherapeutics generate each year? Bolt Biotherapeutics (NASDAQ:BOLT) has a recorded net income of -$69.20 million. BOLT has generated -$1.66 earnings per share over the last four quarters. What is Bolt Biotherapeutics's EPS forecast for next year? Bolt Biotherapeutics's earnings are expected to grow from ($1.61) per share to ($1.12) per share in the next year. More Earnings Resources from MarketBeat Related Companies Fortress Biotech Earnings Date SAB Biotherapeutics Earnings Date Curis Earnings Date Molecular Templates Earnings Date Amgen Earnings Date Gilead Sciences Earnings Date Vertex Pharmaceuticals Earnings Date Regeneron Pharmaceuticals Earnings Date Alnylam Pharmaceuticals Earnings Date Biogen Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Amazon Earnings: 2 Reasons to Love It, 1 Reason to Be CautiousMeta Takes A Bow With Q1 Earnings - Watch For Tariff Impact in Q2Palantir Earnings: 1 Bullish Signal and 1 Area of ConcernVisa Q2 Earnings Top Forecasts, Adds $30B Buyback PlanMicrosoft Crushes Earnings, What’s Next for MSFT Stock?Qualcomm's Earnings: 2 Reasons to Buy, 1 to Stay AwayAMD Stock Signals Strong Buy Ahead of Earnings This page (NASDAQ:BOLT) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredElon Musk is all in on these robots …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | SponsoredAI Boom Takes a Shocking Turn…What 99% of Investors are Missing in AI I believe it could be worth a fortune in the near future, yet hardl...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bolt Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bolt Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
